Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration

Molecular Pharmacology

Volumn 86, Issue 3, 2014, Pages 252-262

  Patel, Maulik ^a   Kawano, Takeharu ^b   Suzuki, Nobuchika ^c   Hamakubo, Takao ^c   Karginov, Andrei V ^a   Kozasa, Tohru ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GASTRIN RELEASING PEPTIDE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROSTAGLANDIN E2; PROTEIN ZO1; RGS PROTEIN; RHO KINASE;

ARTICLE; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CACO-2 CELLS; CELL MOVEMENT; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HT29 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, BOMBESIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84906310126     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.093914     Document Type: Article

References (63)

1. Aittaleb M, Boguth CA, and Tesmer JJG (2010) Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors. Mol Pharmacol 77:111-125.
2. Benitah SA, Valerón PF, and Lacal JC (2003) ROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14:3041-3054. (Pubitemid 36871540)
3. Bian D, Mahanivong C, Yu J, Frisch SM, Pan ZK, Ye RD, and Huang S (2006) The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration. Oncogene 25:2234-2244.
4. Booden MA, Siderovski DP, and Der CJ (2002) Leukemia-associated Rho guanine nucleotide exchange factor promotes G a q-coupled activation of RhoA. Mol Cell Biol 22:4053-4061. (Pubitemid 34556576)
5. Buchanan FG, Wang D, Bargiacchi F, and DuBois RN (2003) Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457. (Pubitemid 37102315)
6. Carman CV, Parent J-L, Day PW, Pronin AN, Sternweis PM, Wedegaertner PB, Gilman AG, Benovic JL, and Kozasa T (1999) Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem 274:34483-34492. (Pubitemid 129511796)
7. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ, and Benya RV (1999) Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol 276:G655-G665. (Pubitemid 29157431)
8. Carroll RE, Ostrovskiy D, Lee S, Danilkovich A, and Benya RV (2000) Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol 58:601-607.
9. Chen Z, Singer WD, Danesh SM, Sternweis PC, and Sprang SR (2008) Recognition of the activated states of Galpha13 by the rgRGS domain of PDZRhoGEF. Structure 16:1532-1543.
10. Corral RS, Iñiguez MA, Duque J, López-Pérez R, and Fresno M (2007) Bombesin induces cyclooxygenase-2 expression through the activation of the nuclear factor of activated T cells and enhances cell migration in Caco-2 colon carcinoma cells. Oncogene 26:958-969.
11. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, and Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826. (Pubitemid 15003742)
12. Ferris HA, Carroll RE, Rasenick MM, and Benya RV (1997) Constitutive activation of the gastrin-releasing peptide receptor expressed by the nonmalignant human colon epithelial cell line NCM460. J Clin Invest 100:2530-2537. (Pubitemid 27514892)
13. Fritz G, Just I, and Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 81:682-687. (Pubitemid 29214373)
14. Frucht H, Gazdar AF, Park JA, Oie H, and Jensen RT (1992) Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52:1114-1122.
15. Fukuhara S, Murga C, Zohar M, Igishi T, and Gutkind JS (1999) A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274:5868-5879. (Pubitemid 29109244)
16. Fukuhara S, Chikumi H, and Gutkind JS (2000) Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho. FEBS Lett 485:183-188.
17. Garcia-Mata R, Wennerberg K, Arthur WT, Noren NK, Ellerbroek SM, and Burridge K (2006) Analysis of activated GAPs and GEFs in cell lysates, in GTPases Regulating Membrane Dynamics (Balch WE, Channing JD, Hall H eds) pp 425-437, Academic Press, New York. (Pubitemid 43207456)
18. Glover S, Nathaniel R, Shakir L, Perrault C, Anderson RK, Tran-Son-Tay R, and Benya RV (2005) Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling. Am J Physiol Gastrointest Liver Physiol 288:G1274-G1282. (Pubitemid 40741082)
19. Härmä V, Knuuttila M, Virtanen J, Mirtti T, Kohonen P, Kovanen P, Happonen A, Kaewphan S, Ahonen I, and Kallioniemi O et al. (2012) Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. Oncogene 31:2075-2089.
20. Harrison SM, Knifley T, Chen M, and O'Connor KL (2013) LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells. BMC Cancer 13:501.
21. Hart MJ, Sharma S, elMasry N, Qiu R-G, McCabe P, Polakis P, and Bollag G (1996) Identification of a novel guanine nucleotide exchange factor for the Rho GTPase. J Biol Chem 271:25452-25458. (Pubitemid 26337919)
22. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, and Bollag G (1998) Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280:2112-2114. (Pubitemid 28366203)
23. Hawcroft G, Volpato M, Marston G, Ingram N, Perry SL, Cockbain AJ, Race AD, Munarini A, Belluzzi A, and Loadman PM et al. (2012) The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility. Br J Pharmacol 166:1724-1737.
24. Hirota CL, Moreau F, Iablokov V, Dicay M, Renaux B, Hollenberg MD, and MacNaughton WK (2012) Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 303:G111-G119.
25. Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, and Nusrat A (2007) Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Am J Physiol Gastrointest Liver Physiol 292:G806-G817. (Pubitemid 46440377)
26. Huang C, Liu S, and Miller RT (2011) Role of p115RhoGEF in the regulation of extracellular Ca(21)-induced choline kinase activation and prostate cancer cell proliferation. Int J Cancer 128:2833-2842.
27. Iwanicki MP, Vomastek T, Tilghman RW, Martin KH, Banerjee J, Wedegaertner PB, and Parsons JT (2008) FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts. J Cell Sci 121:895-905. (Pubitemid 351578125)
28. Jensen RT, Battey JF, Spindel ER, and Benya RV (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42. (Pubitemid 351439216)
29. Karlsson R, Pedersen ED, Wang Z, and Brakebusch C (2009) Rho GTPase function in tumorigenesis. Biochim Biophys Acta 1796:91-98.
30. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, and Sternweis PC (1998) p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280:2109-2111. (Pubitemid 28366202)
31. Lappano R and Maggiolini M (2011) G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10:47-60.
32. Lutz S, Freichel-Blomquist A, Yang Y, Rümenapp U, Jakobs KH, Schmidt M, and Wieland T (2005) The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem 280:11134-11139. (Pubitemid 40418419)
33. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, and Pintzas A (2011) BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol Cancer 10:118.
34. Masica DL and Karchin R (2011) Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res 71:4550-4561.
35. Mikelis CM, Palmby TR, Simaan M, Li W, Szabo R, Lyons R, Martin D, Yagi H, Fukuhara S, and Chikumi H et al. (2013) PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. J Biol Chem 288:12232-12243.
36. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, Tani K, Kobayashi M, Maruyama T, and Kobayashi K et al. (2002) Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 62:28-32. (Pubitemid 34073980)
37. Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T, and Ohta T (2012) Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Oncol Rep 28:777-784.
38. Ong DCT, Ho YM, Rudduck C, Chin K, Kuo WL, Lie DKH, Chua CLM, Tan PH, Eu KW, and Seow-Choen F et al. (2009) LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. Oncogene 28:4189-4200.
39. Radulovic S, Miller G, and Schally AV (1991) Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 51:6006-6009.
40. Ren X-D and Schwartz MA (2000) Determination of GTP loading on Rho. Methods Enzymol 325:264-272.
41. Ridley AJ and Hall A (1992) The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
42. Rigas B, Goldman IS, and Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122:518-523. (Pubitemid 23352474)
43. Rojas RJ, Yohe ME, Gershburg S, Kawano T, Kozasa T, and Sondek J (2007) Galphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain. J Biol Chem 282:29201-29210. (Pubitemid 350043381)
44. Rozengurt E (1998) Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J Cell Physiol 177:507-517.
45. Sahai E and Marshall CJ (2002) RHO-GTPases and cancer. Nat Rev Cancer 2:133-142.
46. Scheschonka A, Dessauer CW, Sinnarajah S, Chidiac P, Shi C-S, and Kehrl JH (2000) RGS3 is a GTPase-activating protein for g(ialpha) and g(qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g(qalpha) and g(11α). Mol Pharmacol 58:719-728.
47. Shang X, Marchioni F, Evelyn CR, Sipes N, Zhou X, Seibel W, Wortman M, and Zheng Y (2013) Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci USA 110:3155-3160.
48. Singer WD, Miller RT, and Sternweis PC (1994) Purification and characterization of the alpha subunit of G13. J Biol Chem 269:19796-19802.
49. Slice LW, Walsh JH, and Rozengurt E (1999) Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter. J Biol Chem 274:27562-27566.
50. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, and Somlyo AP (2000) Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 269:652-659. (Pubitemid 30440356)
51. Struckhoff AP, Rana MK, Kher SS, Burow ME, Hagan JL, Del Valle L, and Worthylake RA (2013) PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA. J Cell Sci 126:4514-4526.
52. Tanabe S, Kreutz B, Suzuki N, and Kozasa T (2004) Regulation of RGS-RhoGEFs by Gα12 and Gα13 Proteins. Methods Enzymol 390:285-294. (Pubitemid 39370658)
53. Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, and Tesmer JJG (2005) Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 310:1686-1690. (Pubitemid 41780792)
54. Thaker NG, Zhang F, McDonald PR, Shun TY, Lewen MD, Pollack IF, and Lazo JS (2009) Identification of survival genes in human glioblastoma cells by small interfering RNA screening. Mol Pharmacol 76:1246-1255.
55. Vigil D, Kim TY, Plachco A, Garton AJ, Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, and Campbell SL et al. (2012) ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res 72:5338-5347.
56. Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, and Glover SC (2007) ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87:1149-1158. (Pubitemid 47609026)
57. Wang D and Dubois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29:781-788.
58. Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, and Neubig RR (2004) Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells. J Biol Chem 279:28831-28834. (Pubitemid 38915749)
59. Wiznerowicz M and Trono D (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77:8957-8961. (Pubitemid 36936105)
60. Xiao H, Zhang Q, Lin Y, Reddy BS, and Yang CS (2008) Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer 122:2115-2124. (Pubitemid 351441204)
61. Yagi H, Tan W, Dillenburg-Pilla P, Armando S, Amornphimoltham P, Simaan M, Weigert R, Molinolo AA, Bouvier M, and Gutkind JS (2011) A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci Signal 4:ra60.
62. Zhang C, Zhang S, Zhang Z, He J, Xu Y, and Liu S (2013) ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc. Oncogene DOI: 10.1038/onc.2013.505. [published ahead of print]
63. Zheng R, Iwase A, Shen R, Goodman OB, Jr, Sugimoto N, Takuwa Y, Lerner DJ, and Nanus DM (2006) Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene 25:5942-5952. (Pubitemid 44477288)